Replies to post #1972 on Spotlight Innovation Inc. (fka STLT)

[Ecomike]

Convertible debt fear is one issue, they have a lot of it, but the two founder CEOs own 66% of the OS, and the current CEO is the one that has been funding it, so he has little reason it seems to PR/pump the stock with fake news.

Recent lay offs of officers is a concern, very late now on the last SEC financial is a big concern.

The Venodol has already been marketed and is sold on line and at stores by Walmart and Amazon. They have patents. The Celtic Biotech company they bought was valued at 3 Million dollars.

With the stock price at .01 and only 30 Mil shares issued, the market cap is now $300,000 or 10% of what they paid for just one company they bought. One of the operations won a $300,000 R&D grant just about 6 months ago. This was at $2, 2 years ago, and .25 earlier this year. Float is just under 10 mil shares, and tightly held as the volume has died down here, not even any tax loss selling now.

And SEC filling, financials would rally it.

Happy Holidays!

[Ecomike]

The bears are back, down 70% or 95% from the ask to the low of the day. Somebody got some bargains today. 1/4 mil share dump, tax loss/estate liquidation, all in one trade. Maybe even margin call on other stuff liquidated the account...

At the .002 low today and just under 10 mil shares in the float...

10,000,000 x .002 = $20,000 value for the entire float. That is just nuts.

They had $500,000 in Venodol Inventory (10-Q), 95% of which had not even been reported as revenue yet, this year, and Walmart selling the product.

Toxic MM AEXG is on the best bid at .0004 now and on the ask at .015

That spread looks like the grand canyon now. I doubt this sell was convertible debt with the 10-Q being so late? The book value of the Celtic Biotech subsidiary was $3 Million dollars. The CEO and prior CEO combined owned the other 20 Mil shares.

Market cap at .0020 is $60,000